Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 19.28% is 23% below its 5-year average of 24.90%, near the high end of its 5-year range (-685.19%–46.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.37% below its 12-month average of 28.10%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 19.28%.
RETURN ON EQUITY (ROE)
19.28%
RETURN ON EQUITY (ROE) AVG TTM
28.10%
RETURN ON EQUITY (ROE) AVG 3Y
28.61%
RETURN ON EQUITY (ROE) AVG 5Y
24.90%
RETURN ON EQUITY (ROE) AVG 10Y
-170.64%
RETURN ON EQUITY (ROE) AVG 15Y
-129.91%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.37%
CURRENT VS 3Y AVG
-32.61%
CURRENT VS 5Y AVG
-22.54%
CURRENT VS 10Y AVG
+111.30%
CURRENT VS 15Y AVG
+114.84%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+145.91%
vs the sector median at left
Puma Biotechnology, Inc.
Market Cap
$483.54M
Return on Equity (ROE)
19.28%
TTM Avg
28.10%
3Y Avg
28.61%
5Y Avg
24.90%
Market Cap
$486.01M
Return on Equity (ROE)
N/A
TTM Avg
-344.79%
3Y Avg
-198.42%
5Y Avg
-104.57%
Market Cap
$475.91M
Return on Equity (ROE)
-24.02%
TTM Avg
-22.16%
3Y Avg
-34.88%
5Y Avg
-37.32%
Market Cap
$472.23M
Return on Equity (ROE)
-8.21%
TTM Avg
-32.76%
3Y Avg
-79.80%
5Y Avg
-71.61%
Market Cap
$471.65M
Return on Equity (ROE)
1.65%
TTM Avg
-27.02%
3Y Avg
-39.92%
5Y Avg
-33.78%
Market Cap
$471.57M
Return on Equity (ROE)
-9.69%
TTM Avg
-30.79%
3Y Avg
-49.02%
5Y Avg
-53.00%
Market Cap
$469.12M
Return on Equity (ROE)
-26.79%
TTM Avg
-28.77%
3Y Avg
-36.48%
5Y Avg
-24.33%
Market Cap
$498.52M
Return on Equity (ROE)
-36.79%
TTM Avg
-82.52%
3Y Avg
-55.07%
5Y Avg
-25.96%
Market Cap
$467.90M
Return on Equity (ROE)
8.25%
TTM Avg
6.54%
3Y Avg
3.79%
5Y Avg
3.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | $483.54M | 19.28% | 28.10% | 28.61% | 24.90% |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | -344.79% | -198.42% | -104.57% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | -24.02% | -22.16% | -34.88% | -37.32% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | -8.21% | -32.76% | -79.80% | -71.61% |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 1.65% | -27.02% | -39.92% | -33.78% |
| Cerus Corporation (CERS)vs › | $471.57M | -9.69% | -30.79% | -49.02% | -53.00% |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -26.79% | -28.77% | -36.48% | -24.33% |
| Oculis Holding AG (OCS)vs › | $498.52M | -36.79% | -82.52% | -55.07% | -25.96% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 8.25% | 6.54% | 3.79% | 3.91% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 11.11% | 8.28% | 4.14% | 1.14% |
ROE
19.3%
ROA
13.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 19.28% |
| 2026-03-31 | 18.99% |
| 2025-12-31 | 23.87% |
| 2025-09-30 | 32.08% |
| 2025-06-30 | 46.27% |
| 2025-03-31 | 39.20% |
| 2024-12-31 | 32.87% |
| 2024-09-30 | 32.69% |
| 2024-06-30 | 17.98% |
| 2024-03-31 | 30.16% |
| 2023-12-31 | 40.40% |
| 2023-09-30 | 9.59% |
| 2023-06-30 | -8.02% |
| 2023-03-31 | 18.59% |
| 2022-12-31 | 0.01% |
| 2022-09-30 | 44.38% |
| 2022-06-30 | -174.69% |
| 2022-03-31 | -685.19% |
| 2021-06-30 | -118.89% |
| 2021-03-31 | -161.43% |
| 2020-06-30 | -177.91% |
| 2020-03-31 | -879.34% |
| 2019-12-31 | -433.05% |
| 2019-09-30 | -553.05% |
| 2019-06-30 | -424.53% |
| 2019-03-31 | -228.36% |
| 2018-12-31 | -331.08% |
| 2018-09-30 | -320.22% |
| 2018-06-30 | -548.21% |
| 2018-03-31 | -423.73% |
| 2017-12-31 | -547.80% |
| 2017-09-30 | -379.67% |
| 2017-06-30 | -240.76% |
| 2017-03-31 | -166.04% |
| 2016-12-31 | -131.58% |
| 2016-09-30 | -290.79% |
| 2016-06-30 | -204.35% |
| 2016-03-31 | -156.29% |
| 2015-12-31 | -116.15% |
| 2015-09-30 | -91.92% |
| 2015-06-30 | -72.97% |
| 2015-03-31 | -57.38% |
| 2014-12-31 | -121.35% |
| 2014-09-30 | -77.98% |
| 2014-06-30 | -53.20% |
| 2014-03-31 | -31.53% |
| 2013-12-31 | -65.10% |
| 2013-09-30 | -63.99% |
| 2013-06-30 | -67.47% |
| 2013-03-31 | -62.82% |
| 2012-12-31 | -57.67% |
| 2012-09-30 | -696.00% |
| 2012-06-30 | -131.26% |
| 2012-03-31 | -51.77% |
| 2011-12-31 | -18.82% |
| 2010-09-30 | -650.00% |
| 2010-06-30 | -762.90% |
